Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease
This study has been completed.
Study NCT00823836
Information provided by GlaxoSmithKline
First Received on January 15, 2009.
Last Updated on October 13, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
